Surien Pharmaceuticals Private Limited

Surien Pharmaceuticals Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials and compliance.
CIN U24232TN2004PTC053031 Incorporated 19 April 2004 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹16.68 Cr
▼ 18.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹2.16 Cr
Issued & subscribed
Open charges
₹20.21 Cr
Satisfied ₹6.06 Cr
Company age
22 yrs
Est. 2004
Last financials
Mar 2024
Balance sheet date

About Surien Pharmaceuticals Private Limited

Data last updated: 18 December 2025

Surien Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 19 April 2004, the company has been in operation for over 22 years.

Registered with ROC Chennai under CIN U24232TN2004PTC053031.

Capital: an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.16 Cr. Formerly known as Shince Pharmaceuticals Private Limited. It is led by directors including Gowri Krishnamoorthy and Ramasamy Krishnamoorthy.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: 108 Chekkadi Street Kovur, Chennai, Tamil Nadu, India – 602101.

As per the financials filed for FY 2025, the company reported a revenue of ₹16.68 Cr, a decline of 18% compared to the previous year.

The company is associated with 1 brand - Surien Pharmaceuticals. As per MCA filings, the company has open charges of ₹20.21 Cr and satisfied charges of ₹6.06 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website surienpharmaceuticals.com.

Company Details of Surien Pharmaceuticals Private Limited
CIN U24232TN2004PTC053031
Registration Number 053031
Incorporation Date 19 April 2004
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    108 Chekkadi Street Kovur, Chennai, Tamil Nadu, India – 602101
  • Industry
    Pharma, Drug Formulation & Development
Company report
Surien Pharmaceuticals Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Surien Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Surien Pharmaceuticals Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Surien Pharmaceuticals Private Limited

Surien Pharmaceuticals Private Limited operates one associated brand: Surien Pharmaceuticals. These brands represent Surien Pharmaceuticals Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Manufactures tablets, capsules, syrups and exports pharmaceutical products globally. surienpharma.in

Competitors & Alternatives of Surien Pharmaceuticals Private Limited

Brands and companies operating in the same space as Surien Pharmaceuticals Private Limited include Merck, Roivant Sciences, AbbVie and 6 more.

Competitor Description Location Founded
Merck Merck Pharmaceutical products are manufactured and marketed worldwide. Kenilworth, United Kingdom, United Kingdom 1891
Roivant Sciences Roivant Sciences Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. New York, United States, United States 2014
AbbVie AbbVie Biopharmaceutical research and drug development are conducted globally by AbbVie. Chicago, United States, United States 2012
Lilly Lilly Traditional pharmaceutical medicines are developed for multiple health fields. United States 1876
Gilead Gilead Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others Foster City, United States, United States 1987
United Therapeutics United Therapeutics Treatments for chronic and life-threatening diseases are developed and commercialized. Silver Spring, United States, United States 1998
Roche Roche Pharmaceuticals and diagnostics kits are developed for various diseases. Basel, Switzerland, Switzerland 1896
MorphoSys MorphoSys Therapeutic antibodies for cancer and other diseases are developed. Planegg, Germany, Germany 1992
Vertex Pharmaceuticals Vertex Pharmaceuticals Developer of drugs for the treatment of multiple disorders United States 1989

Business Activity of Surien Pharmaceuticals Private Limited

Surien Pharmaceuticals Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Surien Pharmaceuticals Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Surien Pharmaceuticals Private Limited

Surien Pharmaceuticals Private Limited is audited by N.R.KRISHNAMOORTHY & CO for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
N.R.KRISHNAMOORTHY & CO Locked Locked Locked
Premium access

Complete auditor history for Surien Pharmaceuticals Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Surien Pharmaceuticals Private Limited

Surien Pharmaceuticals Private Limited is currently managed by 3 directors, with 1 former director having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Gowri Krishnamoorthy Director 21 Apr 2004 22 Years 4 Months Current
Ramasamy Krishnamoorthy Managing Director 21 Apr 2007 19 Years 4 Months Current
Chathurappan Anbazhagan Whole-Time Director 11 Oct 2018 7 Years 11 Months Current

Financials of Surien Pharmaceuticals Private Limited FY 2024 filings available

Surien Pharmaceuticals Private Limited reported revenue of ₹16.68 Cr (down 18.00% YoY) for FY 2025.

Revenue · FY 2025
₹16.68 Cr ▼ 18.00%
Premium access

Ten-year financial statements for Surien Pharmaceuticals Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Surien Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data for Surien Pharmaceuticals Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Surien Pharmaceuticals Private Limited

Open charges
₹20.21 Cr
Satisfied charges
₹6.06 Cr
Breakdown by lending institutions
Others₹11.29 Cr
State Bank of India₹8.92 Cr
Latest charge details
DateLenderAmountStatus
02 Dec 2023 Others ₹52 Lakh Open
22 Sep 2022 Others ₹10.77 Cr Open
04 Sep 2010 State Bank of India ₹8.92 Cr Open
31 Oct 2016 Others ₹1 Cr Satisfied
10 Jan 2009 Karnataka Bank Limited ₹1 Cr Satisfied

Total charge records: 8 View all charges

Employees and EPFO Compliance at Surien Pharmaceuticals Private Limited

View historical data on people associated with Surien Pharmaceuticals Private Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Surien Pharmaceuticals Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Surien Pharmaceuticals Private Limited

Premium access

GST registrations and filing compliance for Surien Pharmaceuticals Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Surien Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Surien Pharmaceuticals Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Surien Pharmaceuticals Private Limited

Premium access

MSME payment history for Surien Pharmaceuticals Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Surien Pharmaceuticals Private Limited

Premium access

Corporate group structure for Surien Pharmaceuticals Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Surien Pharmaceuticals Private Limited

Premium access

MCA filings and documents for Surien Pharmaceuticals Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Surien Pharmaceuticals Private Limited

Activity
30 Sep 2024
Surien Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Activity
31 Mar 2024
Surien Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Charges
02 Dec 2023
A charge with Others amounted to Rs. 0.52 Cr with Charge ID 100828083 was registered on 02 Dec 2023.
Charges
22 Sep 2022
A charge with Others amounted to Rs. 10.77 Cr with Charge ID 100615448 was registered on 22 Sep 2022.
Charges
31 Dec 2021
A charge with State Bank Of India of Rs. 8.92 Cr registered on 04 Sep 2010 with Charge ID 10294826 was modified on 31 Dec 2021.
Directors
11 Oct 2018
Chathurappan Anbazhagan was appointed as a Whole-time director on 11 Oct 2018 & has been associated with this company since 7 years 11 months.

Frequently Asked Questions about Surien Pharmaceuticals Private Limited

Surien Pharmaceuticals Private Limited is an active private limited company in the pharma sector based in Chennai, Tamil Nadu, India. It was incorporated on 19 April 2004 (22+ years old) and is registered under CIN U24232TN2004PTC053031.

Surien Pharmaceuticals Private Limited reported revenue of ₹16.68 Cr for FY 2025 (down 18.00% YoY).

The current directors of Surien Pharmaceuticals Private Limited are:

The primary industry of Surien Pharmaceuticals Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Surien Pharmaceuticals Private Limited can be reached at the registered office: 108 Chekkadi Street Kovur, Chennai, Tamil Nadu, India – 602101, or through the website surienpharmaceuticals.com.

The authorised capital is ₹5 Cr, and the paid-up capital is ₹2.16 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available